Facebook
Linkedin
Twitter
Industries
Aerospace
Agritech
Automotive
BFSI
Biotechnology
Chemicals
Defence Technology
Energy, Power and Sustainability
Food & Beverage
Healthcare
Information Technology
MarTech
Internet Of Things (IOT)
Logistics and Supply Chain
Materials
Medical Devices
Retail
Semiconductor & Electronics
Smart Lighting
Latest News
Interviews
Insights
Guest Post
Staff Writer
Featured Article
Resource Center
Resources
Press Releases
Search
Wednesday, November 13, 2024
Facebook
Linkedin
Twitter
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
ReadMagazine
Industries
All
Aerospace
Agritech
Automotive
BFSI
Biotechnology
Chemicals
Defence Technology
Energy, Power and Sustainability
Food & Beverage
Healthcare
Information Technology
MarTech
Internet Of Things (IOT)
Logistics and Supply Chain
Materials
Medical Devices
Retail
Semiconductor & Electronics
Smart Lighting
Keelvar & DAT Integration Boosts Freight Procurement
Exide Technologies Launches Lithium-Ion Battery for Material Handling
Oglethorpe Power Names Annalisa Bloodworth CEO
Samsung Unveils AI & Automotive Tech at Electronica 2024
Latest News
Interviews
Insights
Guest Post
Staff Writer
Featured Article
Resource Center
Resources
Press Releases
Home
Tags
Phase 2/3 Study
Phase 2/3 Study
Biotechnology
RedHill Biopharma’s Oral Opaganib Significantly Improves Viral Clearance in Phase 2/3 Study in Severely Ill Hospitalized COVID-19 Patients
PR Newswire
-
January 14, 2022
RedHill Biopharma Ltd.("RedHill" or the "Company"), a specialty biopharmaceutical company, announced new data from a prespecified analysis of all oral opaganib's Phase 2/3 study...
0
Fans
Like
3,912
Followers
Follow
0
Subscribers
Subscribe
Hot Topics
Keelvar & DAT Integration Boosts Freight Procurement
Exide Technologies Launches Lithium-Ion Battery for Material Handling
Oglethorpe Power Names Annalisa Bloodworth CEO
Load more
